Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blueberry polyphenol concentrate is a food ingredient derived from blueberry extract, specifically concentrated polyphenolic compounds, which are then sorbed onto grinded buckwheat flour. This concentrate is rich in polyphenols (65.5±0.7 mg-eq. gallic acid/g), anthocyanins (27.3±2.7 mg/g), and flavonoids (1.2±0.1 mg/g), while excluding easily digested carbohydrates like glucose, fructose, and sucrose. It exhibits antioxidant, hypoglycemic, hypolipidemic, and anxiolytic properties. Studies in C57Bl/6 mice with impaired carbohydrate and lipid metabolism induced by a high-fat, high-carbohydrate diet showed that the concentrate significantly reduced fasting blood glucose, insulin, and leptin levels, improved insulin resistance, and decreased hepatic triglycerides and cholesterol. It also demonstrated an anxiolytic effect. The concentrate is being explored for its potential in specialized foods for the prevention of alimentary-dependent diseases such as metabolic syndrome, obesity, and diabetes mellitus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on blueberry polyphenol concentrate.